Editorials |
From the National Institute of Environmental Health Sciences, Research Triangle Park, NC; and Department of Pathology, Duke University Medical Center, Durham, NC.
Correspondence to Elizabeth Murphy, 111 Alexander Dr, Room E216, Mail drop D2-03, Box 12233, NIEHS, Research Triangle Park, NC 27707. E-mail murphy1@niehs.nih.gov
Key Words: Na+/H+ exchange Na+/Ca2+ exchange Ca2+ overload stunning
There are considerable data to support the general
hypothesis that accumulation of
[Na+]i during
ischemia and early reperfusion leads, via
Na+/Ca2+ exchange, to
elevated [Ca2+]i,
resulting in myocardial damage.1 2 3 4 5 6 7 8 9 10 Despite the strong
support for the general aspects of this hypothesis, there is
controversy regarding some details that have important implications for
the design of therapeutic interventions. The relative importance of the
increase in [Na+]i during
ischemia versus the increase in
[Na+]i during reperfusion
in contributing to the rise in
[Ca2+]i and resultant
injury is debated. These issues are important because it has been
suggested that inhibition of the
Na+/H+ exchanger (NHE)
during reperfusion alone would be beneficial. This would allow clinical
intervention after an ischemic episode. It is also important to
understand why an increase in
[Na+]i is detrimental. It
is commonly assumed that
[Na+]i is detrimental
because it leads to increased
[Ca2+]i during
reperfusion, either due to diminished Ca2+ efflux
via Na+/Ca2+ exchange or
due to increased Ca2+ influx due to reverse
Na+/Ca2+ exchange. Recent
data presented by Cross et al9 suggest that
reverse Na+/Ca2+ exchange
is involved in postischemic contractile dysfunction.
However, an increase in
[Na+]i could also be
detrimental because of effects on K+
loss11 or energetics. An understanding of the mechanism
responsible for the detrimental effects of Na+ accumulation
is important for the design of therapeutic interventions. A
study12 published in this issue of Circulation
Research adds new insight into these
This article has been cited by other articles:
![]() |
R. Venkataraman, L. Belardinelli, B. Blackburn, J. Heo, and A. E. Iskandrian A Study of the Effects of Ranolazine Using Automated Quantitative Analysis of Serial Myocardial Perfusion Images J. Am. Coll. Cardiol. Img., November 1, 2009; 2(11): 1301 - 1309. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Hwang, J. M. Arcidi Jr, S. L. Hale, B. Z. Simkhovich, L. Belardinelli, A. K. Dhalla, J. C. Shryock, and R. A. Kloner Ranolazine as a Cardioplegia Additive Improves Recovery of Diastolic Function in Isolated Rat Hearts Circulation, September 15, 2009; 120(11_suppl_1): S16 - S21. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Vie, S. Sablayrolles, R. Letienne, B. Vacher, A. Darmellah, M. Bernard, D. Feuvray, and B. Le Grand 3-(R)-[3-(2-Methoxyphenylthio-2-(S)-methylpropyl]amino-3,4-dihydro-2H-1,5-benzoxathiepine Bromhydrate (F 15845) Prevents Ischemia-Induced Heart Remodeling by Reduction of the Intracellular Na+ Overload J. Pharmacol. Exp. Ther., September 1, 2009; 330(3): 696 - 703. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. N. Sharikabad, J. M. Aronsen, E. Haugen, J. Pedersen, A.-S. W. Moller, H. K. Mork, H. C. D. Aass, O. M. Sejersted, I. Sjaastad, and O. Brors Cardiomyocytes from postinfarction failing rat hearts have improved ischemia tolerance Am J Physiol Heart Circ Physiol, March 1, 2009; 296(3): H787 - H795. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Murphy and D. A. Eisner Regulation of Intracellular and Mitochondrial Sodium in Health and Disease Circ. Res., February 13, 2009; 104(3): 292 - 303. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Stanbouly, L. A. Kirshenbaum, D. L. Jones, and M. Karmazyn Sodium Hydrogen Exchange 1 (NHE-1) Regulates Connexin 43 Expression in Cardiomyocytes via Reverse Mode Sodium Calcium Exchange and c-Jun NH2-Terminal Kinase-Dependent Pathways J. Pharmacol. Exp. Ther., October 1, 2008; 327(1): 105 - 113. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. L. Hale and R. A. Kloner The Antianginal Agent, Ranolazine, Reduces Myocardial Infarct Size but Does Not Alter Anatomic No-Reflow or Regional Myocardial Blood Flow in Ischemia/Reperfusion in the Rabbit Journal of Cardiovascular Pharmacology and Therapeutics, September 1, 2008; 13(3): 226 - 232. [Abstract] [PDF] |
||||
![]() |
E. Murphy and C. Steenbergen Ion Transport and Energetics During Cell Death and Protection Physiology, April 1, 2008; 23(2): 115 - 123. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Murphy and C. Steenbergen Mechanisms Underlying Acute Protection From Cardiac Ischemia-Reperfusion Injury Physiol Rev, April 1, 2008; 88(2): 581 - 609. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. F. Pedersen, S. A. King, E. B. Nygaard, R. R. Rigor, and P. M. Cala NHE1 Inhibition by Amiloride- and Benzoylguanidine-type Compounds: INHIBITOR BINDING LOCI DEDUCED FROM CHIMERAS OF NHE1 HOMOLOGUES WITH ENDOGENOUS DIFFERENCES IN INHIBITOR SENSITIVITY J. Biol. Chem., July 6, 2007; 282(27): 19716 - 19727. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Couvreur, L. Lucats, R. Tissier, A. Bize, A. Berdeaux, and B. Ghaleh Differential effects of postconditioning on myocardial stunning and infarction: a study in conscious dogs and anesthetized rabbits Am J Physiol Heart Circ Physiol, September 1, 2006; 291(3): H1345 - H1350. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. L. Hale, J. A. Leeka, and R. A. Kloner Improved Left Ventricular Function and Reduced Necrosis after Myocardial Ischemia/Reperfusion in Rabbits Treated with Ranolazine, an Inhibitor of the Late Sodium Channel J. Pharmacol. Exp. Ther., July 1, 2006; 318(1): 418 - 423. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. F. Pedersen, M. E. O'Donnell, S. E. Anderson, and P. M. Cala Physiology and pathophysiology of Na+/H+ exchange and Na+-K+-2Cl- cotransport in the heart, brain, and blood Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2006; 291(1): R1 - R25. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. R. Chaitman Ranolazine for the Treatment of Chronic Angina and Potential Use in Other Cardiovascular Conditions Circulation, May 23, 2006; 113(20): 2462 - 2472. [Full Text] [PDF] |
||||
![]() |
K Terashima, A Takeuchi, N Sarai, S Matsuoka, E.B Shim, C.H Leem, and A Noma Modelling Cl- homeostasis and volume regulation of the cardiac cell Phil Trans R Soc A, May 15, 2006; 364(1842): 1245 - 1265. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. E. Anderson, H. Liu, A. Beyschau, and P. M. Cala Effects of cold cardioplegia on pH, Na, and Ca in newborn rabbit hearts Am J Physiol Heart Circ Physiol, March 1, 2006; 290(3): H1090 - H1097. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Imahashi, C. Pott, J. I. Goldhaber, C. Steenbergen, K. D. Philipson, and E. Murphy Cardiac-Specific Ablation of the Na+-Ca2+ Exchanger Confers Protection Against Ischemia/Reperfusion Injury Circ. Res., October 28, 2005; 97(9): 916 - 921. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Omelchenko, R. Bouchard, S. Shurraw, M. Trac, M. Hnatowich, and L. V. Hryshko Frequency-dependent regulation of cardiac Na+/Ca2+ exchanger Am J Physiol Heart Circ Physiol, October 1, 2005; 289(4): H1594 - H1603. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. E. Anderson, D. M. Kirkland, A. Beyschau, and P. M. Cala Acute effects of 17{beta}-estradiol on myocardial pH, Na+, and Ca2+ and ischemia-reperfusion injury Am J Physiol Cell Physiol, January 1, 2005; 288(1): C57 - C64. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Murphy Primary and Secondary Signaling Pathways in Early Preconditioning That Converge on the Mitochondria to Produce Cardioprotection Circ. Res., January 9, 2004; 94(1): 7 - 16. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Davies, S. B. Digerness, S. P. Goldberg, C. R. Killingsworth, C. R. Katholi, P. S. Brookes, and W. L. Holman Intra-myocyte ion homeostasis during ischemia-reperfusion injury: effects of pharmacologic preconditioning and controlled reperfusion Ann. Thorac. Surg., October 1, 2003; 76(4): 1252 - 1258. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Reffelmann and R. A. Kloner Is microvascular protection by cariporide and ischemic preconditioning causally linked to myocardial salvage? Am J Physiol Heart Circ Physiol, April 1, 2003; 284(4): H1134 - H1141. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. I Bak and J. S Ingwall Contribution of Na+/H+ exchange to Na+ overload in the ischemic hypertrophied hyperthyroid rat heart Cardiovasc Res, March 15, 2003; 57(4): 1004 - 1014. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Babsky, S. Hekmatyar, S. Wehrli, N. Doliba, M. Osbakken, and N. Bansal Influence of Ischemic Preconditioning on Intracellular Sodium, pH, and Cellular Energy Status in Isolated Perfused Heart Experimental Biology and Medicine, July 1, 2002; 227(7): 520 - 528. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. An, S. G. Varadarajan, E. Novalija, and D. F. Stowe Ischemic and anesthetic preconditioning reduces cytosolic [Ca2+] and improves Ca2+ responses in intact hearts Am J Physiol Heart Circ Physiol, October 1, 2001; 281(4): H1508 - H1523. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. G Allen and X.-h. Xiao Na+ entry during ischemia, reperfusion and preconditioning Cardiovasc Res, April 1, 2001; 50(1): 164 - 166. [Full Text] [PDF] |
||||
![]() |
S. G. Varadarajan, J. An, E. Novalija, S. C. Smart, and D. F. Stowe Changes in [Na+]i, compartmental [Ca2+], and NADH with dysfunction after global ischemia in intact hearts Am J Physiol Heart Circ Physiol, January 1, 2001; 280(1): H280 - H293. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. W.T Fiolet Reperfusion injury and ischemic preconditioning: two sides of a coin? Cardiovasc Res, November 1, 2000; 48(2): 185 - 187. [Full Text] [PDF] |
||||
![]() |
X-H. Xiao and D.G. Allen Activity of the Na+/H+ exchanger is critical to reperfusion damage and preconditioning in the isolated rat heart Cardiovasc Res, November 1, 2000; 48(2): 244 - 253. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. El Banani, M. Bernard, D. Baetz, E. Cabanes, P. Cozzone, A. Lucien, and D. Feuvray Changes in intracellular sodium and pH during ischaemia-reperfusion are attenuated by trimetazidine: Comparison between low- and zero-flow ischaemia Cardiovasc Res, September 1, 2000; 47(4): 688 - 696. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. R. Ford, A. S. Clanachan, and B. I. Jugdutt Characterization of Cardioprotection Mediated by AT2 Receptor Antagonism After Ischemia-Reperfusion in Isolated Working Rat Hearts Journal of Cardiovascular Pharmacology and Therapeutics, January 1, 2000; 5(3): 211 - 221. [Abstract] [PDF] |
||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1999 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |